Hydromorphone metabolites: isolation and identification from pooled urine samples of a cancer patient

References

• BERRANG, B., TWINE, C. E., HENNESSEE, G. L. and CARROLL, F. I., 1975, Synthesis of morphine-3-glucuronide. Synthetic Communications, 5, 231–236.
   Web of Science ®Google Scholar
• BOERNER, U., ABBOTT, S. and ROE, R. L., 1975, The metabolism of morphine and heroin in man. Drug Metabolism Reviews, 4,39–73.
   PubMed Web of Science ®Google Scholar
• BRODSKY, J. B., CHAPLAN, S. R., BROSE, W. G. and MARK, J. B. D., 1990, Continuous epidural hydromorphone for postthoracotomy pain relief. Annals of Thoracic Surgery, 50, 888–893.
   PubMed Web of Science ®Google Scholar
• BRUERA, E., BRENNEIS, C., MICHAUD, M., MACMILLAN, K., HANSON, J. and MACDONALD, R. N., 1988, Patient-controlled subcutaneous hydromorphone versus continuous subcutaneous infusion for the treatment of cancer pain. Journal of the National Cancer Institute, 80, 1152–1154.
   PubMed Web of Science ®Google Scholar
• BRUERA, E., MACEACHERN, T., MACMILLAN, K., MILLER, M. J. and HANSON, J., 1993, Local tolerance to subcutaneous infusions of high concentrations of hydromorphone: a prospective study. Journal of Pain Symptoms and Management, 8, 201–204.
   PubMed Web of Science ®Google Scholar
• BUDAVARI, S. (ed.), Merck Index, 1989, 11th edn (Rahway: Merck).
   Google Scholar
• CHATTERPE, N., INTLIRRISI, C. E., DAYTON, H. B. and BLUMBERG, H., 1975, Stereospecific synthesis of the 60-hydroxy metabolites of naltrexone and naloxone. Journal of Medicinal Chemistry, 18, 490–492.
   PubMed Web of Science ®Google Scholar
• CONE, E. J. and DARWIN, W. D., 1978, Simultaneous determination of hydromorphone, hydrocodone and their 6a- and 60-hydroxy metabolites in urine using selected ion recording with methane chemical ionization. Biomedical Mass Spectrometry, 5, 291–295.
   PubMedGoogle Scholar
• CONE, E. J., PHELPS, B. A. and GORODETZKY, C. W., 1977, Urinary extraction of hydromorphone and metabolites in humans, rats, dogs, guinea pigs, and rabbits. Journal of Pharmaceutical Sciences, 66, 1709–1713.
   PubMed Web of Science ®Google Scholar
• DOUGHERTY, T. B., BAYSINGER, C. L., HENENBERGER, J. C. and GOODING, D. J., 1989, Epidural hydromorphone with and without epinephrine for post-operative analgesia after cesarean delivery. Anesthesia and Analgesia, 68, 318–322.
   PubMed Web of Science ®Google Scholar
• EDDY, N. B., 1933, Dilaudid (dihydromorphinone hydrochloride). Journal of the American Medical Association, 100, 1032–1035.
   Google Scholar
• FERRIS, F. D., KERR, I. G., DE ANGELIS, C., SONE, M and HUME, S., 1990, Inpatient narcotic infusions for patients with cancer pain. Journal of Palliative Care, 6, 51–59.
   Google Scholar
• GONG, Q.-L., HEDNER, T., HEDNER, J., BJORKMAN, R. and NORDBERG, G., 1991, Antinociceptive and ventilatory effects of the morphine metabolites: morphine-6-glucuronide and morphine-3-glucuronide. European Journal of Pharmacology, 193, 47–56.
   Google Scholar
• HAGEN, N., THIRLWELL, M. P., DHALIWAL, H. S., BABUL, N., HARSANYI, Z. and DARKE, A. C., 1995, Steady-state pharmacokinetics of hydromorphone and hydromorphone-3-glucuronide in cancer patients after immediate and controlled-release hydromorphone. Journal of Clinical Pharmacology, 35, 37–44.
   PubMed Web of Science ®Google Scholar
• HANNA, M. H., PEAT, S. J., WOODHAM, M., KNIBB, A. and FUNG, C., 1990, Analgesic efficacy and CSF pharmacokinetics of intrathecal morphine-6-glucuronide: comparison with morphone. British Journal of Anaesthesia, 64, 547–550.
   PubMed Web of Science ®Google Scholar
• HAYS, H., HAGEN, N., THIRWELL, M., DHALIWAL, H., BARuL, N., HARSANYI, Z. and DARKE, A. C., 1994, Comparative clinical efficacy and safety of immediate release and controlled release hydromorphone for chronic severe cancer pain. Cancer, 74, 1808–1816.
   PubMed Web of Science ®Google Scholar
• LEE, J. W., PEDERSEN, J. E., MORAVETZ, T. L., DZERK, A. M., MUNDT, A. D. and SHEPARD, K. V., 1991, Sensitive and specific radioimmunoassays for opiates using commercially available materials. I: Methods for the determinations of morphine and hydromorphone. Journal of Pharmaceutical Sciences, 80, 284–288.
   PubMed Web of Science ®Google Scholar
• LIBRACH, S. L., 1991, Adverse effects of opioids. In The Pain Manual: Principles and Issues in Cancer Pain Management (Montreal: Pegasus Healthcare), pp. 58–66.
   Google Scholar
• LIU, S., CARPENTER, R. L., MULROY, M. F., WEISSMAN, R. M., McGILL, T. J., Rupp, S. M. and ALLEN, H. M., 1995, Intravenous versus epidural administration of hydromorphone. Anesthesiology, 82, 682–688.
   PubMed Web of Science ®Google Scholar
• MAHLER, D. L. and FORREST, W. H., JR., 1975, Relative analgesic potencies of morphine and hydromorphone in postoperative pain. Anesthesiology, 42, 602–607.
   PubMed Web of Science ®Google Scholar
• MOULIN, D. E., KREEFT, J. H., MURRAY-PARSONS, N. and BOUQUILLON, A. I., 1991, Comparison of continuous subcutaneous and intravenous hydromorphone infusions for management of cancer pain. Lancet, 337, 465–468.
   Google Scholar
• OKUDA, S., YAMAGUCHI, S., KAWAZOE, Y. and TSUDA, K., 1964, Studies on morphine alkaloids. I. Nuclear magnetic resonance spectral studies on morphine alkaloids. Chemical and Pharmaceutical Bulletin, 12, 104–112.
   PubMed Web of Science ®Google Scholar
• OSBORNE, R., THOMPSON, P., JOEL, S., TRW, D., PATEL, N. and SLEVIN, M., 1992, The analgesic activity of morphine-6-glucuronide. British Journal of Clinical Pharmacology, 34, 130–138.
   PubMed Web of Science ®Google Scholar
• PARAB, P. V., RITSCHEL, W. A., COYLE, D. E., GREGG, R. V. and DENSON, D. D., 1988, Pharmacokinetics of hydromorphone after intravenous, peroral and rectal administration to human subjects. Biopharnzaceutics and Drug Disposition, 9, 187–199.
   PubMed Web of Science ®Google Scholar
• ROERIG, S., FUJIMOTO, J. M. and WANG, R. I. H., 1973, Isolation of hydromorphone and dihydromorphine glucuronides from urine of the rabbit after hydromorphone administration (37291). Proceedings of the Society for Experimental Biology and Medicine, 143, 230–233.
   PubMed Web of Science ®Google Scholar
• ROERIG, S., FUJIMOTO, J. M., WANG, R. I. H., POLLOCK, S. H. and LANGE, D., 1976, Preliminary characterization of enzymes for reduction of naloxone and naltrexone in rabbit and chicken liver. Drug Metabolism and Disposition, 4, 53–58.
   Google Scholar
• SEARLE, N. R., ROY, M., BERGERON, G., PERRAULT, J., ROOF, J., HEERMANS, C., COURTEMANCHE, M., DEMERS, C. and CARTE R., 1994, Hydromorphone patient-controlled analgesia (PCA) after coronary artery bypass surgery. Canadian Journal of Anaesthesia, 41, 198–205.
   PubMed Web of Science ®Google Scholar
• SMALL, L. F., EDDY, N. B., MOSETTIG, E. and HIMMELSBACH, C. K., 1938, Studies on drug addiction. United States Public Health Reports, Suppl. 138, 1–35.
   Google Scholar
• SMALL, L. F. and LUTZ, R. E., 1932, Chemistry of the opium alkaloids. United States Public Health Reports, Suppl. 103, 159.
   Google Scholar
• THOMPSON, P. I., JOEL, S. P., JOHN, L., WEDZICHA, J. A., MACLEAN, M. and SLEVIN, M. L., 1995, Respiratory depression following morphine and morphine-6-glucuronide in normal subjects. British Journal of Clinical Pharmacology, 40, 145–152.
   PubMed Web of Science ®Google Scholar
• VANIER, M.-C., LABRECQUE, G., LEPAGE-SAVARY, D., POULIN, E., PROVENCHER, L. and LAMONTAGNE, C., 1993, Comparison of hydromorphone continuous subcutaneous infusion and basal rate subcutaneous infusion plus PCA in cancer pain. Pain, 53, 27–32.
   PubMed Web of Science ®Google Scholar
• WALLENSTEIN, S. L., HOUDE, R. W., PORTENOY, R., LAPIN, J., ROGERS, A. and FOLEY. K. M., 1990, Clinical analgesic assay of repeated and single doses of heroin and hydromorphone. Pain, 41, 5–13.
   Google Scholar
• YOSHIMURA, H., OGURI, K. and TSUKAMOTO, H., 1968, Metabolism of drugs. LX. The synthesis of codeine and morphine glucuronides. Chemical and Pharmaceutical Bulletin, 16, 2114–2119.
   PubMed Web of Science ®Google Scholar
• ZAW-TUN, N. and BRUERA, E., 1992, Active metabolites of morphine. Journal of Palliative Care, 8, 48–50.
   PubMedGoogle Scholar